LENZ Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	448	152	193	722	-	-
Market Cap Growth	30.37%	-21.30%	-73.26%	-	-	-
Enterprise Value	235	86	-69	355	-20	2
PE Ratio	-	-1.22	-1.91	-10.20	-	-
PB Ratio	2.26	-1.64	0.65	1.88	-	-
P/FCF Ratio	-1.83	-1.54	-2.04	-12.32	-	-
P/OCF Ratio	-2.00	-1.69	-2.19	-13.66	-	-
EV/EBITDA Ratio	0.24	-0.73	0.75	-5.17	0.29	-75.83
EV/EBIT Ratio	0.23	-0.69	0.69	-5.01	0.29	-75.83
EV/FCF Ratio	0.27	-0.87	0.73	-6.05	1.93	-115.74
Debt / Equity Ratio	0.00	0.00	0.02	0.03	-	-0.99
Debt / EBITDA Ratio	0.00	0.00	-0.06	-0.16	-	-76.03
Debt / FCF Ratio	0.00	0.00	-0.06	-0.19	-	-116.05
Quick Ratio	11.30	3.55	20.56	31.19	0.62	0.00
Current Ratio	11.47	3.63	21.11	31.44	0.66	0.00
Interest Coverage	-	-	-	-	-1708.32	-0.36
Return on Equity (ROE)	-88.00%	-81.50%	-30.80%	-26.20%	202.20%	-
Return on Assets (ROA)	-55.80%	-53.40%	-29.10%	-20.40%	-605.90%	-
Return on Capital (ROIC)	-62.94%	146.12%	-34.97%	-15.29%	20.64%	223.08%
Earnings Yield	-26.20%	-82.03%	-52.34%	-9.80%	-	-
FCF Yield	-22.65%	-65.13%	-48.99%	-8.12%	-	-
Dividend Yield	41.11%	0.00%	0.00%	0.00%	-	-
Buyback Yield / Dilution	-141.85%	-3.90%	-89.75%	-1166.12%	-	-
Total Shareholder Return	-100.74%	-3.90%	-89.75%	-1166.12%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).